DROXIA
Hydroxyurea
- Strength
- 300 mg/1
- Form
- Capsule
- Class
- Antimetabolite
Waylis Therapeutics LLC
Listed by Major Pharmaceuticals
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Antimetabolite |
| Approval route | ANDA — approved generic |
| NDC code | 0904-6939 |
| FDA application | ANDA075340 |
| RxNorm concept | 197797 |
| Package sizes listed | 1 |
| Marketed since | February 1999 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Hydroxyurea
Waylis Therapeutics LLC
HYDROXYUREA
H2-Pharma LLC
HYDROXYUREA
H2-Pharma LLC
Hydroxyurea
Waylis Therapeutics LLC
Hydroxyurea
Waylis Therapeutics LLC
HYDROXYUREA
H2-Pharma LLC
HYDROXYUREA
H2-Pharma LLC
Hydroxyurea
Waylis Therapeutics LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.